Related Experiment Video
Updated: Dec 29, 2025

Dynamic Continuous Blood Extraction from Rat Heart via Noninvasive Microdialysis Technique
Published on: September 13, 2022
Small Molecules with Big Impacts on Cardiovascular Diseases.
Fatemeh Mirzadeh Azad1, Maedeh Arabian2, Majid Maleki2
1Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
MicroRNAs (miRNAs) are key regulators in cardiovascular diseases (CVDs). This review explores miRNA roles in cardiac remodeling, arrhythmias, and atherosclerosis, highlighting their therapeutic potential for CVD.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Genetics
Background:
- Cardiovascular diseases (CVDs) remain a leading global health burden.
- Despite advances, complex pathobiology necessitates novel biomarkers and therapies.
- MicroRNAs (miRNAs) are critical gene regulators implicated in various diseases.
Purpose of the Study:
- To review the current understanding of miRNA involvement in cardiovascular diseases.
- To detail the roles of miRNAs in cardiac remodeling, arrhythmias, and atherosclerosis.
- To discuss emerging therapeutic strategies utilizing miRNAs for CVD treatment.
Main Methods:
- Comprehensive literature review of studies on miRNAs and cardiovascular diseases.
- Analysis of research on miRNA deregulation in cardiac pathophysiology.
- Synthesis of findings on miRNA-based therapeutic applications.
Main Results:
- MicroRNAs are significantly deregulated in multiple cardiovascular conditions.
- miRNA dysregulation impacts cardiovascular homeostasis, differentiation, and function.
- Specific miRNAs are linked to cardiac remodeling, arrhythmias, and atherosclerosis progression.
Conclusions:
- MicroRNAs represent promising biomarkers and therapeutic targets for cardiovascular diseases.
- Targeting miRNAs offers potential for novel interventions in CVD management.
- Further research into miRNA mechanisms and applications is crucial for advancing cardiovascular medicine.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Types of Signaling Molecules
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
